Shopping Cart 0
Cart Subtotal
USD 0

Global Biotechnology

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Global Biotechnology

Summary

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Global biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The global biotechnology industry had total revenues of USD 380.2bn in 2017, representing a compound annual growth rate (CAGR) of 9.6% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 218bn, equivalent to 57.3% of the industry's overall value.

- The medical/healthcare segment has become more lucrative as the global population ages, adding pressure for new drugs to be researched and developed to treat conditions associated with old age.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Global biotechnology market by value in 2017?

- What will be the size of the Global biotechnology market in 2022?

- What factors are affecting the strength of competition in the Global biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the global's biotechnology market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Amgen, Inc. 20

Covance Inc. 23

F. Hoffmann-La Roche Ltd 24

Merck & Co., Inc. 28

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33


List Of Figure

List of Figures

Figure 1: Global biotechnology industry value: USD billion, 2013-17

Figure 2: Global biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Global biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the global biotechnology industry, 2017

Figure 6: Drivers of buyer power in the global biotechnology industry, 2017

Figure 7: Drivers of supplier power in the global biotechnology industry, 2017

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2017

Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2017

Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2017

Figure 11: Amgen, Inc.: revenues & profitability

Figure 12: Amgen, Inc.: assets & liabilities

Figure 13: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 14: F. Hoffmann-La Roche Ltd: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities


List Of Table

List of Tables

Table 1: Global biotechnology industry value: USD billion, 2013-17

Table 2: Global biotechnology industry category segmentation: USD billion, 2017

Table 3: Global biotechnology industry geography segmentation: USD billion, 2017

Table 4: Global biotechnology industry value forecast: USD billion, 2017-22

Table 5: Amgen, Inc.: key facts

Table 6: Amgen, Inc.: key financials (USD )

Table 7: Amgen, Inc.: key financial ratios

Table 8: Covance Inc.: key facts

Table 9: F. Hoffmann-La Roche Ltd: key facts

Table 10: F. Hoffmann-La Roche Ltd: key financials (USD )

Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 12: F. Hoffmann-La Roche Ltd: key financial ratios

Table 13: Merck & Co., Inc.: key facts

Table 14: Merck & Co., Inc.: key financials (USD )

Table 15: Merck & Co., Inc.: key financial ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Global Biotechnology

Summary

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Global biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

- The global biotechnology industry had total revenues of USD 380.2bn in 2017, representing a compound annual growth rate (CAGR) of 9.6% between 2013 and 2017.

- The medical/healthcare segment was the industry's most lucrative in 2017, with total revenues of USD 218bn, equivalent to 57.3% of the industry's overall value.

- The medical/healthcare segment has become more lucrative as the global population ages, adding pressure for new drugs to be researched and developed to treat conditions associated with old age.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in the global

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the globalbiotechnology market

- Leading company profiles reveal details of key biotechnology market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Global biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Global biotechnology market by value in 2017?

- What will be the size of the Global biotechnology market in 2022?

- What factors are affecting the strength of competition in the Global biotechnology market?

- How has the market performed over the last five years?

- What are the main segments that make up the global's biotechnology market?

READ MORE

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Category segmentation 10

Geography segmentation 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 15

New entrants 16

Threat of substitutes 18

Degree of rivalry 19

Leading Companies 20

Amgen, Inc. 20

Covance Inc. 23

F. Hoffmann-La Roche Ltd 24

Merck & Co., Inc. 28

Methodology 31

Industry associations 32

Related MarketLine research 32

Appendix 33

About MarketLine 33


List Of Figure

List of Figures

Figure 1: Global biotechnology industry value: USD billion, 2013-17

Figure 2: Global biotechnology industry category segmentation: % share, by value, 2017

Figure 3: Global biotechnology industry geography segmentation: % share, by value, 2017

Figure 4: Global biotechnology industry value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the global biotechnology industry, 2017

Figure 6: Drivers of buyer power in the global biotechnology industry, 2017

Figure 7: Drivers of supplier power in the global biotechnology industry, 2017

Figure 8: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2017

Figure 9: Factors influencing the threat of substitutes in the global biotechnology industry, 2017

Figure 10: Drivers of degree of rivalry in the global biotechnology industry, 2017

Figure 11: Amgen, Inc.: revenues & profitability

Figure 12: Amgen, Inc.: assets & liabilities

Figure 13: F. Hoffmann-La Roche Ltd: revenues & profitability

Figure 14: F. Hoffmann-La Roche Ltd: assets & liabilities

Figure 15: Merck & Co., Inc.: revenues & profitability

Figure 16: Merck & Co., Inc.: assets & liabilities


List Of Table

List of Tables

Table 1: Global biotechnology industry value: USD billion, 2013-17

Table 2: Global biotechnology industry category segmentation: USD billion, 2017

Table 3: Global biotechnology industry geography segmentation: USD billion, 2017

Table 4: Global biotechnology industry value forecast: USD billion, 2017-22

Table 5: Amgen, Inc.: key facts

Table 6: Amgen, Inc.: key financials (USD )

Table 7: Amgen, Inc.: key financial ratios

Table 8: Covance Inc.: key facts

Table 9: F. Hoffmann-La Roche Ltd: key facts

Table 10: F. Hoffmann-La Roche Ltd: key financials (USD )

Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF)

Table 12: F. Hoffmann-La Roche Ltd: key financial ratios

Table 13: Merck & Co., Inc.: key facts

Table 14: Merck & Co., Inc.: key financials (USD )

Table 15: Merck & Co., Inc.: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com